September 03, 2014
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
Dermira files $75 million IPO
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Dermira filed recently with the U.S. Securities and Exchange Commission to raise up to $75 million in an initial public offering.
Founded in 2010, the company plans to list on the NASDAQ under the symbol DERM, according to a press release.
The filing was initially made confidentially by Rhythm Pharmaceuticals on June 26.
Joint book runners for the deal are Citi and Leerink. No pricing terms were disclosed, according to the release.